Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	446.18	284.12	422.64	352.98	147.46	121.79
Trading Asset Securities	-	-	-	-	200.31	341.06
Cash & Short-Term Investments	446.18	284.12	422.64	352.98	347.78	462.85
Cash Growth	6.76%	-32.77%	19.73%	1.50%	-24.86%	644.14%
Accounts Receivable	397.05	416.78	374.28	318.43	326.39	222.79
Other Receivables	14.72	11.89	16.48	10.47	13.56	12.03
Receivables	411.77	428.67	390.76	328.89	339.95	234.82
Inventory	627.74	532.13	406.92	226.46	135.51	106.21
Other Current Assets	246.52	219.16	131.43	141.7	39.81	48.62
Total Current Assets	1,732	1,464	1,352	1,050	863.06	852.5
Property, Plant & Equipment	3,828	3,844	3,213	2,620	951.83	528.43
Long-Term Investments	124.39	124.45	123.45	112.4	40	7
Other Intangible Assets	148.58	150.04	137.73	86.28	73.17	43.98
Long-Term Deferred Tax Assets	128.09	145.3	86.54	49.39	40.48	14.39
Long-Term Deferred Charges	15.11	13.64	5.79	-	-	-
Other Long-Term Assets	49.89	33.51	71.17	51.9	58.54	27.8
Total Assets	6,026	5,775	4,989	3,970	2,027	1,474

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	616.71	712.68	564.03	589.01	221.64	99.87
Accrued Expenses	29.46	52.07	44	36.87	35.06	17.95
Short-Term Debt	221.09	123.38	681.98	915.12	79.23	18.5
Current Portion of Long-Term Debt	421.16	363.03	225.75	26.6	-	-
Current Income Taxes Payable	11.91	3.58	4.92	25.5	5.32	6.67
Current Unearned Revenue	32.24	17	17.4	12.77	19.61	17.57
Other Current Liabilities	95.19	67.59	65.45	70.61	27.9	22.34
Total Current Liabilities	1,428	1,339	1,604	1,676	388.75	182.89
Long-Term Debt	1,725	1,572	637.81	304.93	-	-
Long-Term Unearned Revenue	91.81	94.75	87.62	91.53	102.63	86.23
Long-Term Deferred Tax Liabilities	112.42	136.32	102.07	71.64	54.05	21.85
Total Liabilities	3,357	3,143	2,431	2,145	545.44	290.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	250.12	250.12	249.72	157.54	108.4	108.4
Additional Paid-In Capital	1,218	1,218	1,209	603.46	624.47	588.04
Retained Earnings	1,271	1,228	1,158	1,110	758.99	498.69
Treasury Stock	-50.01	-50.01	-53.61	-45.24	-12	-12
Comprehensive Income & Other	-0.1	0.43	0.96	0.72	0.64	-
Total Common Equity	2,688	2,647	2,565	1,827	1,480	1,183
Minority Interest	-19.39	-14.82	-6.27	-1.31	1.15	-
Shareholders' Equity	2,669	2,632	2,558	1,826	1,482	1,183
Total Liabilities & Equity	6,026	5,775	4,989	3,970	2,027	1,474

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,367	2,059	1,546	1,247	79.23	18.5
Net Cash (Debt)	-1,921	-1,775	-1,123	-893.67	268.55	444.35
Net Cash Growth	-	-	-	-	-39.56%	6128.38%
Net Cash Per Share	-7.75	-7.10	-4.86	-3.90	1.18	2.14
Filing Date Shares Outstanding	247.63	248.79	235.72	227.71	227.91	227.91
Total Common Shares Outstanding	247.63	248.79	235.72	227.71	227.91	227.91
Working Capital	304.43	124.76	-251.78	-626.43	474.3	669.61
Book Value Per Share	10.86	10.64	10.88	8.02	6.50	5.19
Tangible Book Value	2,540	2,497	2,427	1,741	1,407	1,139
Tangible Book Value Per Share	10.26	10.04	10.30	7.64	6.17	5.00
Buildings	-	862.98	755.99	462.42	290.67	200.66
Machinery	-	2,449	1,307	952.21	703.78	439.11
Construction In Progress	-	1,192	1,606	1,529	188.91	65.33

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error